Moneycontrol PRO
Loans
HomeNewsIpcalaboratories

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Karnataka Bank, Polaris, Ipca Lab: Sharmila Joshi

    Sharmila Joshi of Peerless Securities is bullish on Karnataka Bank, Aditya Birla Nuvo, Polaris Financial Technology and Ipca Laboratories.

  • Bull's Eye: Buy Karnataka Bank, RComm, Punj Lloyd

    Bull's Eye: Buy Karnataka Bank, RComm, Punj Lloyd

    Sharmila Joshi of Peerless Securities advised buying Karnataka Bank with a target price of Rs 151 and keep a stoploss at Rs 145.

  • Buy Dabur, Ipca Labs, Escorts; sell Titan: Sharmila Joshi

    Buy Dabur, Ipca Labs, Escorts; sell Titan: Sharmila Joshi

    Sharmila Joshi of Peerless Securities is bearish on Titan Industries. She advised selling the scrip with a stop loss at Rs 295.50.

  • Bull's Eye: Buy Dabur, Escorts; sell Crompton, Adani Ent

    Bull's Eye: Buy Dabur, Escorts; sell Crompton, Adani Ent

    Sharmila Joshi of Peerless Securities advised going short on Titan Industries June future with a target price of Rs 285 and keep a stoploss at Rs 295.50.

  • Expect big upside in Ipca Labs, says Sudarshan Sukhani

    Expect big upside in Ipca Labs, says Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com expects big upside in Ipca Laboratories. “The stock has been consolidating for last seven days. That consolidation could be a small flag, breaking on the upside and confirming that larger move is still ahead,” he reasons.

  • Buy Syndicate Bank, Ipca Labs, Jain Irrigation: Mukadam

    Buy Syndicate Bank, Ipca Labs, Jain Irrigation: Mukadam

    Shahina Mukadam of Varun Capital has recommended buy rating on Syndicate Bank, Ipca Laboratories, Jain Irrigation and Tata Global Beverages.

  • Hold Ipca Laboratories: Pankaj Jain

    Hold Ipca Laboratories: Pankaj Jain

    Ipca Laboratories is doing exceedingly well on all fronts. The company has a very strong research and development (R&D) department, so one should hold on to it, says Pankaj Jain, Director, Sunteck Wealthmax Capital Pvt Ltd.

  • What stocks you should buy/avoid coming week?

    What stocks you should buy/avoid coming week?

    Manoj Sachdeva, Research Head of Hem Securities teams up with Moneycontrol.com to answer investor queries.

  • Buy PFC, Pantaloon, City Union Bank: Mukadam

    Buy PFC, Pantaloon, City Union Bank: Mukadam

    In CNBC-TV18's popular show Bull's Eye, Shahina Mukadam, Fairwealth Securities shares trading strategy of the day.

  • Prefer Glenmark, Ipca Labs, says PN Vijay

    Prefer Glenmark, Ipca Labs, says PN Vijay

    One can prefer Glenmark Pharma and Ipca Labs, says PN Vijay, Portfolio Manager.

  • See lot of speculative upside in ADAG stocks: PN Vijay

    See lot of speculative upside in ADAG stocks: PN Vijay

    In an interview to CNBC-TV18, portfolio manager PN Vijay spoke about various stocks, sector and all that is making news in the market right now.

  • Bull's eye: Buy RCom, PFC, Dena Bank, OBC

    Bull's eye: Buy RCom, PFC, Dena Bank, OBC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Go long in Ipca Laboratories: Sukhani

    Go long in Ipca Laboratories: Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can go long in Ipca Laboratories.

  • Short Sintex Industries, IVRCL; Buy Ipca Labs: Pankaj Jain

    Short Sintex Industries, IVRCL; Buy Ipca Labs: Pankaj Jain

    In CNBC-TV18's popular show Bull's Eye, Pankaj Jain, Sunteck Wealthmax shares trading strategy of the day.

  • Bull's Eye: Short IFCI, IVRCL, Yes Bank; buy MCX

    Bull's Eye: Short IFCI, IVRCL, Yes Bank; buy MCX

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Glenmark Pharma, Ipca Labs: Diwan

    Buy Glenmark Pharma, Ipca Labs: Diwan

    Prakash Diwan, Prakash Diwan's Wealth Circle is of the view that Glenmark Pharma, Ipca Laboratories both stocks offer very good entry at the current levels.

  • See upside potential in IPCA Labs: Sukhani

    See upside potential in IPCA Labs: Sukhani

    See upside potential in IPCA Labs, says Sudarshan Sukhani, s2analytics.com.

  • Buy IndusInd Bank, SREI Infra, Infotech: Joshi

    Buy IndusInd Bank, SREI Infra, Infotech: Joshi

    In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi of sharmilajoshi.com shares trading strategy of the day.

  • Bull's Eye: Infotech Enterprises, Ashok Leyland, SREI Infra

    Bull's Eye: Infotech Enterprises, Ashok Leyland, SREI Infra

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Ipca Labs, KPIT Cummins, Kolte-Patil: Sharmila Joshi

    Buy Ipca Labs, KPIT Cummins, Kolte-Patil: Sharmila Joshi

    In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi, sharmilajoshi.com shares trading strategy of the day.

  • Bull's eye: Buy Ipca Labs, Dabur, L&T, short JSPL

    Bull's eye: Buy Ipca Labs, Dabur, L&T, short JSPL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Ipca Labs, Ranbaxy Labs: Pankaj Jain

    Buy Ipca Labs, Ranbaxy Labs: Pankaj Jain

    In CNBC-TV18's popular show Bull's Eye, Pankaj Jain, Sunteck Wealthmax shares trading strategy of the day.

  • Bull's eye: Buy Opto Circuits, Ceat; short NCC, R Power

    Bull's eye: Buy Opto Circuits, Ceat; short NCC, R Power

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Drug makers in India to sustain 'premium' valuations: HSBC

    Drug makers in India to sustain 'premium' valuations: HSBC

    HSBC raises target prices for some Indian drug makers saying "robust" earnings will help sustain the "premium" valuations in the sector.

  • Bull's Eye: Buy HDIL, Ipca Labs, Unitech

    Bull's Eye: Buy HDIL, Ipca Labs, Unitech

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347